We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Exposure to Light While Pregnant Essential for Eye Development

By HospiMedica International staff writers
Posted on 05 Feb 2013
A new study reveals important information about retinopathy prematurity that causes blindness in premature babies.

Researchers at Children's Hospital Medical Center (CHMC; Cincinnati, OH, USA) and the University of California, San Francisco (UCSF; USA) used mouse models to examine the light-response pathway. More...
To do so, they raised mice in both darkness and in a regular day-night cycles, starting at late term pregnancy, to examine the outcomes on vascular progression of the eye. The scientists confirmed the purpose of the light response pathway by changing an opsin gene in mice known as Opn4 that creates melanopsin; in other words, stopping the initiation of the photo pigment.


The researchers found that the mice with mutated Opn4, as well as those that were raised in darkness, showed similar random expansion of hyaloid vessels and unusual retinal vascular progression, powered by the protein vascular endothelial growth factor (VEGFA). The researchers showed that these vascular anomalies are explained by a light-response pathway that suppresses retinal neuron number, limits hypoxia, and as a consequence, holds local expression of VEGFA in check to ward off indiscriminate vascular expansion.

According to the study, the light-response pathway must occur during pregnancy in order to achieve the precisely planned program that creates a normal eye; it is crucial for the right number of photons to reach the mother's body by late term pregnancy. The researchers also saw that photons of light trigger melanopsin inside the fetus—not the mother—to aid development of healthy blood vessel and retinal neurons in the eye. Another function of the light-response pathway is to prepare the eye for vision by regulating retinal neuron number and initiating a series of events that ultimately pattern the ocular blood vessels. The study was published on January 16, 2013, in Nature.

“This fundamentally changes our understanding of how the retina develops,” said study coauthor Richard Lang, PhD, of the division of pediatric ophthalmology. “We have identified a light-response pathway that controls the number of retinal neurons. This has downstream effects on developing vasculature in the eye and is important because several major eye diseases are vascular diseases.”

Related Links:

Children's Hospital Medical Center
University of California, San Francisco




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.